New diabetes clinical trial: A Real-world Study of Immunotherapy Combination Regimens for Treating Liver Cancer in Cold Regions

Published on: 2026-06-12T04:00:00Z
Conditions: Liver Cancer
Interventions: Drug: Immune Checkpoint Inhibitors
Sponsors: Harbin Medical University; Liaoning Cancer Hospital & Institute; China-Japan Union Hospital, Jilin University; First Affiliated Hospital of Harbin Medical University; The Second Affiliated Hospital of Harbin Medical University
Active, not recruiting
https://ift.tt/b54nTz1